Machines could assemble molecules like Lego bricks

A new approach in chemistry suggests that small organic molecules could be built by machines using repeated, standardized steps, similar to assembling with Lego blocks. Researchers propose breaking a molecule down into a set of reusable pieces and attaching them one by one, with automation handling assembly and purification between steps. The idea aims to simplify production and expand the kinds of molecules that can be made with machines.

What is the new method and why it matters

The approach, described in a study cited by researchers such as Martin D. Burke from the University of Illinois Urbana-Champaign, treats molecule-building as a sequence of repeatable operations rather than a single, complex procedure. A carbon-based molecule is viewed as a framework of blocks that can be assembled in a fixed order. Each piece (a “blocc”) contributes part of the final structure, and blocks are connected through carbon–carbon bonds. This could enable automation to perform a limited, standardized set of actions—assembling blocks and purifying between steps—rather than mimicking every human-made variation in chemistry.

Key facts to know

• The proposed process uses pre-prepared blocks and a repeatable sequence to build molecules.
• Automation would handle repetitive assembly and purification tasks between steps.
• More than 300 molecular building blocks exist in this approach, with demonstrations in laboratories.
• It moves away from trying to replicate every human chemist’s maneuver and toward standardized operations.

Who could be affected

Researchers and manufacturers in chemical and pharmaceutical fields could benefit from faster, more predictable production of small molecules. If validated at scale, the method might broaden access to certain medicines and materials by enabling automated synthesis with fewer bespoke steps.

Practical next steps for users and readers

• Watch for independent verification and demonstrations of the method beyond initial labs.
• Track any published data on scalability, cost, and safety for automated molecule assembly.
• Note any shifts in how labs document procedures when using standardized building-block workflows.
• Be aware that this is described as an approach and not yet proven at industrial scale in all contexts.

Limits and questions

Details about how broadly the approach will apply to different molecule types, reaction choices, and real-world manufacturing costs are not yet provided. It remains to be seen how automation handles all needed purification, quality control, and regulatory requirements for finalized products.

Information and responsibility notice: This article is general information based on the cited material available when published. It is not legal, tax, immigration, medical, financial, banking, or investment advice; it does not create a professional-client relationship; and it is not a guarantee of outcome, availability, accuracy, or eligibility. Rules, schedules, prices, and third-party information can change. Confirm material decisions with the relevant authority and an appropriately qualified adviser before acting.